| 注册
首页|期刊导航|实用肿瘤杂志|HER2阳性晚期胃癌患者MDT诊治报道一例

HER2阳性晚期胃癌患者MDT诊治报道一例

卢瑗瑗 李剑平 王新 刘娜 潘妍 李莉 张筱茵 王建宏 郑建勇 任静 赵娓娓

实用肿瘤杂志2018,Vol.33Issue(2):95-102,8.
实用肿瘤杂志2018,Vol.33Issue(2):95-102,8.

HER2阳性晚期胃癌患者MDT诊治报道一例

MDT diagnosis and treatment of a case of HER2-positive advanced stage gastric cancer

卢瑗瑗 1李剑平 2王新 1刘娜 1潘妍 1李莉 1张筱茵 1王建宏 1郑建勇 1任静 3赵娓娓3

作者信息

  • 1. 第四军医大学西京消化病医院,国家消化系统疾病临床研究中心,陕西西安710032
  • 2. 第四军医大学西京医院放疗科,陕西西安710032
  • 3. 第四军医大学西京医院放射科,陕西西安710032
  • 折叠

摘要

Abstract

This article describes the process of multi-disciplinary diagnosis and treatment of a HER2-positive advanced stage gastric cancer.The patient was diagnosed as advanced stage gastric cancer with multiple unresectable metastases in the neck,abdominal and mediastinal lymph nodes at the time of initial diagnosis.After multidisciplinary discussion,the patient received first-line chemotherapy combined with trastuzumab treatment,second-line chemotherapy combined with brain metastases radiotherapy,and third-line alternative chemotherapy regimen together with trastuzumab rechallenge and multiple other therapeutic approaches.Finally,the patient reached an overall survival of 25 months.The prognosis of patients with advanced gastric cancer is poor.Multi-disciplinary collaboration can integrate the treatment strategies,ensure that the patients have received reasonable individualized comprehensive treatment,and effectively extend the patient survival time.

关键词

胃肿瘤/诊断/胃肿瘤/治疗/受体,表皮生长因子/拮抗剂和抑制剂/抗体,单克隆/治疗应用/综合疗法

Key words

stomach neoplasms/diagnosis/stomach neoplasms/therapy/receptor, epidermal growth factor/antagonists & inhibitors/antibodies, monoclonal/therapeutic use/combined modality therapy

分类

医药卫生

引用本文复制引用

卢瑗瑗,李剑平,王新,刘娜,潘妍,李莉,张筱茵,王建宏,郑建勇,任静,赵娓娓..HER2阳性晚期胃癌患者MDT诊治报道一例[J].实用肿瘤杂志,2018,33(2):95-102,8.

基金项目

国家自然科学基金(81472701,81572929) (81472701,81572929)

实用肿瘤杂志

OACSTPCD

1001-1692

访问量0
|
下载量0
段落导航相关论文